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Infection with dengue virus presents a broad clinical spectrum, which can range from asymptomatic cases to severe cases that are
characterised by haemorrhagic syndrome and/or shock. The reason for such variability remains unknown. This work evaluated
the in vitro permissiveness of mouse, rat, hamster, and guinea pig macrophages to infection by dengue virus 2 (DENV2). The
results established that macrophages derived from the BALB/c mouse strain showed higher permissiveness to DENV2 infection
than macrophages from other rodent species, although all rodent species studied had the C820T mutation in the oligoadenylate
synthetase 1b gene, indicating no relationship to the diﬀerent in vitro susceptibilities of mouse cells at this locus. Other molecular
mechanisms related to ﬂavivirus susceptibility remain to be explored.
1.Introduction
Infection with dengue virus (DENV) causes dengue and
severe dengue (formerly dengue fever and dengue haemor-
rhagic fever). DENV belongs to the Flaviviridae family,
ﬂavivirusgenus.DENVisanenvelopedvirus,anditsgenome
consistsofapositivepolarity,single-strandedRNAofaround
11kb that encodes ten proteins. DENV can replicate in sev-
eral types of cells, including dendritic cells, B and T lym-
phocytes, endothelial cells, hepatocytes, and neuronal cells.
However, monocytes/macrophages are the primary target
during in vivo infection [1]. Viral entry into these cells
enablesthevirustospreadtodiﬀerenttissuesandinducesthe
presentation HLA molecule-associated viral antigens. The
presentation of viral antigens by macrophages to memory T
cells induces T cell activation and, consequently, the prolifer-
ation and production of cytokines such as TNF-α,I F N ,a n d
IL-2. This set of cytokines and chemokines induces endothe-
lial dysfunction and plasma leakage, both of which are char-
acteristic of more severe manifestations of the disease [2].
Several studies have addressed the relationship between
humangenesandthesusceptibilitytodenguevirusinfection.
For example, the HLA-A∗0203 allele correlated with dengue
fever (DF) in Thai children, while HLA-A∗0207 correlated
with dengue haemorrhagic fever (DHF). Moreover, the
allelesHLA-B44,B62,B76,andB77conferprotectionagainst
DHF in secondary infections [3]. Other polymorphisms
associated with DHF have been found in the genes for DC-
SIGN1, TNF-α,F c - γ receptors, vitamin D receptors, and
mannose binding lectin [4, 5]. In addition to these host
factors, there is evidence that DENV serotypes 2 and 3 cause
DHF more frequently [6], supporting the belief that both
host and virus factors can aﬀect the clinical outcome of
patients.
Recent studies have identiﬁed the oligoadenylate synthe-
tase 1b (Oas1b) gene as being responsible for susceptibility/
resistance to West Nile Virus (WNV) infection in mice, and
it is therefore a potential candidate gene for the Flv locus
[7, 8]. These seminal works found a non-sense mutation
(C820T) in the Oas1b gene, exon 4, that was linked to
susceptibility to WNV infection. This mutation replaces an
arginine with a stop codon, producing a truncated protein
lacking the C-terminal domain. Knock-in of a normal Oas1b
allele induced resistance to Yellow Fever Virus infection in
a susceptible mouse strain, which was comparable to the
resistance observed in resistant congenic mice [9]. These
results led to the conclusion that the Oas1b gene conferred
resistance against ﬂavivirus infection. However, a neuronal2 Journal of Tropical Medicine
cell line expressing the complete form of the Oas1b protein
showed only a slight reduction in virus yield and was not
signiﬁcantly diﬀerent from the same neuronal cell line ex-
pressing the truncated form [10]. Likewise, transfecting
cDNA from the complete Oas1b gene into susceptible em-
bryonicﬁbroblastsdidnotinduceacompletereversiontothe
resistant phenotype [11]. Together, these results suggest that
murine resistance to Flavivirus infection is not completely
understood in vitro and that other cellular and animal mod-
elsshouldbestudied.Thisworkevaluatedthepermissiveness
to DENV infection and evaluated the presence of the C820T
polymorphism in the Oas1b gene obtained from diﬀerent
rodentspecies,includingthreestrainsofmouse,rat,hamster,
and guinea pig.
2.MaterialsandMethods
2.1. Animals and Cells. Experiments with animals were ap-
proved by the Universidad El Bosque’s Ethics Committee
following the national legislation. Diﬀerent 6–8-week-old
rodent species were used and were obtained from the
Colombian National Institute of Health’s animal facility. The
animalsusedwereBALB/cinbredmice(Mus musculus),NIH
Swiss outbred mice, CD1 (ICR) Swiss outbred mice, Syrian
hamsters (Mesocricetus auratus), Wistar rats (Rattus norvegi-
cus), and Hartley strain guinea pigs (Cavia porcellus). Two
millilitres of 1.5% carboxymethylcellulose was injected in-
traperitoneally into two animals from each species and this
was done twice in diﬀerent days. After 48 hours, the animals
wereeuthanized,andaperitonealwashwasmadewithRPMI
1640mediumplus10%foetalbovineserum,100U/mLpeni-
cillin, 10μg/mL streptomycin, and 2,5μg/mL amphotericin
(complete medium-CM). The medium was collected and
centrifuged, and the cell pellet was then suspended in CM.
Then, 200,000 cells were seeded into 12-well culture dishes
and 10,000 cells were seeded in 24-well culture dishes using
round glass coverslips. Nonadherent cells were removed 48
hours later, and the culture of adherent cells continued for a
further 5 days to allow for cytokine clearance. Adherent cells
were considered to be peritoneal macrophages, as previously
described [12]. The cells were seeded in duplicate from each
animal used.
2.2. Virus and Infection. The virus was obtained by infecting
C6/36HT cells with a DENV serotype 2 (COL-789) isolate
donated by Dr. Jairo M´ endez from the Colombian Institute
of Health’s Virology Group and titrated on LLCMK-2 cells.
The virus was placed in contact with the macrophages for 1
hour at 37◦C at a multiplicity of infection (MOI) of 1 and
0.1; it was then removed, fresh medium was added, and the
cells were kept for 24, 48, and 72 hours, at which time they
were processed.
2.3.PlasmidConstructionandqPCR. Acapsidgenefragment
ampliﬁed from DENV2 RNA was used to construct a plas-
mid as published previously [13], and a dilution having
1010 copies/μL wasprepared.RNAwasextractedfrominfect-
edanduninfectedmacrophagesupernatantsandmonolayers
using Trizol LS and Trizol reagents, respectively, (Invitrogen)
and reverse-transcribed using the M-MLV enzyme and ran-
dom primers. The SYBR Green and the GeneAmp 5700
sequence detection system (Perkin-Elmer Corporation) were
used for the real-time PCR assay. A DENV capsid gene frag-
ment was ampliﬁed using DV2C-L and DV2C-R primers.
Samples lacking cDNA were used as negative controls, and
cDNA obtained from viral inoculums was used as positive
controls. The data obtained from the monolayers were an-
alysed using the relative quantiﬁcation method based on the
assumption of ideal ampliﬁcation eﬃciency with a doubling
product every cycle, followed by twofold changes in ﬂuores-
cence intensity (which could be calculated using the 2−ΔΔCT
formula) and β-actin as the housekeeping gene [14]. Abso-
lute quantiﬁcation was used for analysing the data obtained
from the supernatants by producing a six-point standard
curve (107–102 copies/μL) from the pDV2core plasmid (107–
102 molecules) that was obtained as previously described
[13]. This curve was simultaneously processed with the
samples and evaluated 24, 48, and 72 hours p.i. Data were
analysed using ANOVA and a Least Signiﬁcant Diﬀerence
post hoc test and P<0.05 was considered signiﬁcant. Two
independent experiments were done, and two animals were
used from each species in each one. Independent duplicates
o fc e ll sw e r es e e d e df o re a c ha n i m a l( n = 8 ) ;e a c hs a m p l ew a s
processed by duplicate in qPCR experiments.
2.4. Immunocytochemistry and TUNEL Assay. Infected and
noninfected cells were ﬁxed with 4% paraformaldehyde
for the same deﬁned periods and then permeabilised with
0.1% Triton X-100. Infected cells were detected by using
monoclonal antiﬂavivirus antibody (Chemicon, MAB8744).
Biotinylated anti-mouse IgG antibody was used as the
secondary antibody and detected with peroxidase-coupled
streptavidin, and 0.05% diaminobenzidine and 0.01% H2O2
were used as the developing reagents. Other cultures were
incubated with biotinylated dUTP and the TdT enzyme
for detecting DNA fragmentation (as an apoptotic indi-
cator); after being washed, samples were incubated with
Cy3-coupled streptavidin. The cultures were visualised and
counted in a Wild Leitz GmBH ﬂuorescence microscope.
One-way ANOVA was done, and when the overall ANOVA
resulted in a P value less than 0.05, Least Signiﬁcant Differ-
ence (LSD) test was carried out for comparing infected cell
counts and values from viral RNA quantiﬁcation.
2.5. Obtaining and Sequencing DNA. Brain DNA was ob-
tained from each rodent species using phenol/chloroform
extraction and precipitated with sodium acetate and ethanol.
This DNA was used to amplify an Oas1b gene exon 4
fragment using OAS-1bR: 5 -CTG GGA GTA TGG GAG
TCG AG-3  and OAS-1bL: 5 -GCT GTT GGT GCA GGT
ATT CA-3  primers, which amplify the gene region between
nucleotides 771–925. The PCR product was puriﬁed and
sequenced.
3. Results
3.1. Dengue Virus Replication Eﬃciency among Diﬀerent
Rodent Macrophages. The number of viral copies released byJournal of Tropical Medicine 3
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Figure 1: qRT-PCR to obtain absolute quantiﬁcation of viral copies yielded to supernatants from diﬀerent rodent species’ peritoneal
macrophages cultures. (a) Cells infected at a MOI 0,1 and (b) MOI 1. ∗∗P<0.01.
themacrophagesintothesupernatantwasquantiﬁedbyreal-
timePCRanalysisoftheRNAobtainedfromthesupernatant
of cells infected for 24, 48, and 72 hours at two diﬀerent
MOIs.Figure 1(a)showsthattheviralcopynumberobtained
from BALB/c-derived macrophage supernatants infected
with DENV at an MOI of 0,1 in all post-infection (p.i.)
times was 4–25 times larger than that obtained from NIH-
and ICR-derived mouse macrophages. The diﬀerences in the
number of viral copies were signiﬁcant at 24 and 48 hours
p.i. (P<0.01), while the number of viral copies obtained
in BALB/c-derived macrophages was similar to that obtained
in NIH- and ICR-derived mouse macrophages at 72 hours.
Similar ﬁndings were established in macrophages from tax-
onomically diﬀerent rodent species, such as rats, hamsters,
and guinea pigs, where highly signiﬁcant diﬀerences were
found (P<0.01).
When the macrophages were infected at an MOI of 1
(Figure 1(b)), signiﬁcant diﬀerences were observed 24 hours
p.i. when BALB/c donors were compared to NIH mice, ham-
sters, and guinea pigs (P<0.01). No diﬀerence in the viral
copy number were found in the supernatants at 48 and 72
hours p.i.
A larger number of viral RNA copies were found in
BALB/c-derived macrophage supernatants from cells infect-
ed with an MOI of 0.1 than with an MOI of 1 (Figure 1(a)
versus Figure 1(b)). There were no diﬀerences among viral
copies when the infection was carried out at an MOI of 0.1
or 1 in the other animals (P>0.05). Relative RNA viral
quantitation was carried out from macrophage monolayers
and showed that the amount of virus found in cells was pro-
portional to the amount of virus released to the supernatant.
The relative viral RNA quantity was signiﬁcantly larger in
BALB/c macrophages, from 4-fold (BALB/c versus hamster)
to 5400-fold (BALB/c versus ICR) higher at an MOI of
0,1, and from 4-fold (BALB/c versus hamster) to 8100-fold
(BALB/c versus ICR) at an MOI of 1 (P<0.05, see Figure 2).
Diﬀerences in relative expression levels were much more
marked than the diﬀerences found in the absolute quantiﬁ-
cation of the supernatants. The data obtained from the other
rodent species did not reveal any signiﬁcant diﬀerences when
comparing diﬀerent MOIs, nor when comparing the three
p.i times. With the exception of the lower relative viral RNA
levels found in NIH mouse macrophages, the levels of viral
RNA tended to decrease as the p.i. time increased (Figure 2).
3.2. Infected and Apoptotic Macrophages from Diﬀerent
Rodents. Immunocytochemistry was used to detect viral an-
tigens in macrophages from the six diﬀerent rodent species
studied. As previously described [15], speciﬁc immunoreac-
tivity was observed that corresponded to viral antigens in the
infected cell cytoplasm (having punctiform characteristics)
in the perinuclear region. A signiﬁcantly larger number
of infected macrophages was found in BALB/c-derived
macrophages compared with other rodent macrophage cul-
tures (Figure 3(c)). Approximately 43% of the macrophages
from BALB/c mice inoculated with an MOI of 1 showed
evidence of infection 24 hours p.i., increasing to 100% at 48
hours p.i.; an 81% infection of macrophages was reached at
an MOI of 0.1, but only at 72 hours p.i. infection percentages
were much lower in cells from the other animals (see
Table 1). A large number of positively stained extracellular
vesicles were also observed in BALB/c-derived macrophages
(Figure 3(b)), but they were not observed in macrophages
from other species (Figure 3(c)). Macrophages inoculated
with DENV at an MOI of 1 presented a high percentage
of DNA fragmentation, as demonstrated by TUNEL. High
apoptotic percentages were found from 24 hours p.i. (88%)
onwards and remained high up to 48 and 72 hours p.i. (91
and 99%, resp.). In infected macrophages from rodent spe-
cies other than BALB/c, the percentage of TUNEL-positive
cells was similar to that found in control cells that had not
been infected with DENV (Table 1). An interesting ﬁnding
was that the apoptotic percentages in macrophages from
BALB/c mice inoculated with DENV at an MOI of 0,1 did
not correlate with the percentages for DENV-positive cells.
While 79% of the cells had become infected 48 hours after-
infection, only 8% were apoptotic; the same phenomena oc-
curred at 72 hours (81% versus 5%).4 Journal of Tropical Medicine
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
v
i
r
a
l
 
R
N
A
0.01
0.1
1
10
100
1000
10000
24 h 48 h 72 h
∗
∗
∗
∗
∗∗
Balb/c
NIH
Rat
Guinea pig
Hamster
ICR
(a)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
v
i
r
a
l
 
R
N
A
0.01
0.1
1
10
100
1000
10000
24 h 48 h 72 h
∗∗
∗∗
∗∗
(b)
Figure 2: qRT-PCR to obtain relative quantiﬁcation of viral copies obtained from monolayers from diﬀerent rodents’ peritoneal
macrophages cultures. The fold change of viral RNA was calculated from DENV-infected macrophage monolayers, normalising the data
obtained against noninfected control and against β-actin at 0,1MOI (a) and at 1MOI (b) and evaluated 24, 48, and 72 hours p.i. ∗P<0.05,
∗∗P<0.01.
(a) (b)
(c)
Figure 3: Immunocytochemistry for DENV2-infected or noninfected macrophages. (a) Noninfected macrophage control. (b) Macrophages
from DENV-infected BALB/c mice at 1MOI, 72 hours p.i. Observe the staining in almost all cells (arrows). Note the extracellular vesicles
immunoreactive to viral antigen (arrow heads). (c) Hamster macrophages DENV-infected at MOI 1, 72 hours p.i. The stained cells show an
intracytoplasmatic viral antigen distribution; the other animals showed a similar labelling pattern. The bars correspond to 40μm.
3.3.PresenceoftheC820TMutation. Analysingthesequences
from the Oas1b gene exon 4 fragment obtained from BALB/c
mouse genomic DNA revealed that they were consistent
with those reported previously [7, 8]. The TGA stop codon
mutation inserts a premature translation stop in the Oas1b
gene in these mice. Interestingly, the other rodent species
analysed also had the C820T mutation, which leads to the
translation of a truncated protein in all cases. The sequences
from this Oas1b fragment from guinea pigs, hamsters, and
NIH and ICR mice had not been previously identiﬁed and
werereportedtoGenBank(Caviaporcellusaccessionnumber
EF081023, Rattus norvegicus accession number EF081022,
Mus musculus NIH strain accession number EF081021, Mus
musculus ICR strain accession number EF081020, Mesocrice-
tus auratus accession number EF081019, Mus musculus
BALB/c strain accession number EF081018).Journal of Tropical Medicine 5
Table 1: Percentage of infected and positive TUNEL cultured macrophages from diﬀerent rodents.
0.1MOI 1MOI
MOCK 24h 48h 72h 24h 48h 72h
TUNEL DENV+ TUNEL DENV+ TUNEL DENV+ TUNEL DENV+ TUNEL DENV+ TUNEL DENV+ TUNEL
BALB/c 4.0 13.2 5.2 79.8 8.2 81.4 5.0 43.4 88.6 100 91 86.8 99.2
ICR 13.0 26.6 9.2 21.8 17.0 22.6 13.6 13.2 4.6 25.6 23.6 34.2 17.0
NIH 8.0 5.8 5.0 12.2 9.4 15.6 31.0 9.2 9.4 13.8 29.2 17.2 9.2
Rat 2.0 24.4 4.6 17.8 5.2 23 7.4 20.6 5.6 13.6 4.2 8.0 6.3
Guinea
pig 5.2 5.2 3.2 12.4 8.6 24.4 4.6 5.2 6.0 17.8 8.0 29.6 3.8
Hamster 7.0 13.4 12.0 32.8 34.8 8.6 33.2 6.4 3.0 5.4 17.0 10 15.2
The data represent the percentage of DENV antigen positive over the total of cells counted. Note that only 43.4% of the cells were positive for viral antigen in
BALB/c mouse macrophage infected with 1MOI, 24 hours p.i., but almost all the cells presented DNA degradation. Two animals were used from each species;
two groups of independent cells were seeded for each animal and two replicates were done for each of them in immunocytochemistry and TUNEL assays (n =
8).
4. Discussion
Genetic markers for host susceptibility to infection could
provide answers for questions concerning why not all indi-
viduals infected by DENV become ill and why they do not
all have similar symptoms if they do become ill. The clinical
manifestations of dengue virus infection range from undif-
ferentiatedfevertoseveresystemiccompromise,encephalitis,
and haemorrhagic syndrome. The reason why infection with
DENV (and the ﬂavivirus in general) causes clinical mani-
festations in only a small percentage of infected individuals
remains unknown. However, it has been suggested that the
host’s genetic factors could be involved. The resistance of
some mice strains to infection by some ﬂavivirus has been
described since the beginning of the twentieth century ([11]
reviewed in [16]), and it was initially found that ﬂavivirus
resistance to infection was inherited as a dominant trait [17].
It is known that the monocyte/macrophage system is the
primary in vivo cellular target for DENV, and the peritoneal
macrophage model has also been used to study ﬂavivirus
resistance and susceptibility. In this work, it was found that
macrophages from BALB/c mice had higher permissiveness
toDENV2infectionusingqPCRandimmunocytochemistry.
Sequence analysis of the Oas1b gene demonstrated that all
four rodent species studied had the C820T mutation, leading
to the supposition that the production of a truncated protein
b yt h i sg e n o t y p ed o e sn o ta ﬀect DENV susceptibility.
WiththeexceptionofBALB/cmice,allrodentstrainsand
species of macrophages studied have a low capacity to sup-
port DENV2 replication because infection with the virus did
not cause large amounts of RNA to assemble or be released
as virions. This ﬁnding could contradict the suggestion of a
protective mechanism involving viral packaging, as has been
previously proposed [18]. The results found in NIH mouse-
derived macrophages could suggest that these cells not only
have a cellular mechanism that reduces permissiveness but
also have a more eﬃcient viral clearance process. Neverthe-
less,itisimportanttoclearthattheseresultsareonlyrelevant
for dengue virus serotype 2; it is probable that diﬀerent
results could be found for other dengue serotypes.
Like other studies, we did ﬁnd more viral copies in
supernatants in any of the cultures that had been inoculated
with an MOI of 0.1 relative to those with an MOI of 1. Brin-
ton [19] suggested that this ﬁnding could be due to the
presence of defective interfering (DI) particles found in
greater amounts at a higher MOI. The production of DI
particles could be facilitated by some mechanism in resistant
cells, while highly susceptible cells will mainly produce
infectious virus. In turn, this higher virus production leads
to greater cell death in highly susceptible cells. The theory is
supported by the work done by Espina et al. [20], who used
human monocytes as their model. Despite the infected cell
percentage in BALB/c-derived macrophages is similar with
both MOIs, infection at an MOI of 1 induced a signiﬁcantly
higher number of TUNEL-positive cells. It seems that the in-
fection of cells with a high MOI activates proapoptotic mo-
lecular routes as a mechanism to block viral replication and
dissemination during viral infection, thereby explaining this
ﬁnding. However, the virus could be activating anti-apop-
totic routes at a low MOI and improving cell survival. It has
been previously established that DENV induces apoptosis
in diﬀerent cell types (e.g., endothelial cells, hepatocytes,
dendritic cells, monocytes, and neuroblastoma cells) [21].
The proapoptotic mechanisms that are related to DENV
infection include apoptosis activation by the extrinsic route
(via ligands such as TNF-α and Apo2/TRAIL) [22]a n d
the intrinsic route (described in neuroblastoma cells having
phospholipase A2 activation, superoxide anion production,
cytochrome c release, followed by caspase 3 activation). A
mechanism related to apoptosis has not been previously
proposed in work studying resistance and susceptibility to
ﬂavivirusinfection.Theresultsofthepresentstudydisplayed
a clear relationship between lower susceptibility to infection
and decreased apoptosis. This ﬁnding suggests that the con-
trol of apoptosis-inducing mechanisms may represent a ma-
crophage protection strategy in addition to it control of viral
replication, a phenomenon that deserves more investigation.
It would also be necessary to consider in the study of
these cells susceptibility to dengue virus infection, the recent
ﬁndings of Kwan et al. [23], in which Monocyte-derived6 Journal of Tropical Medicine
dermal macrophages were capable of internalizing live
DENV but they displayed an inherent resistance to viral
growth because virus particles accumulate into poorly acidi-
ﬁed phagosomes, which prevents release of the nucleocapsid
intothecytoplasm,andthereforeitslaterreplication.Togeth-
er, these results suggest an additional level of complexity in
the genetic control of ﬂavivirus replication.
5. Conclusions
This work can conclude that BALB/c mice macrophages had
higher permissiveness to DENV2 infection as it showed
higher viral copies when measuring by using qPCR and im-
munocytochemistry. Besides, sequence analysis demon-
strated that Balb/C, NIH, and ICR mice as well as rat, ham-
ster, and guinea pig had the C820T mutation in Oas1b gene.
It is needed to carry out more studies to clarify which is
themolecularpathwayinvolvedinthishigherpermissiveness
and if it is related to some apoptotic pathway.
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